191 related articles for article (PubMed ID: 22410553)
41. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
42. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis.
Kim JH; Kim JH; Oh M; Yu YS; Kim KW; Kwon HJ
Mol Pharm; 2009; 6(2):513-9. PubMed ID: 19718802
[TBL] [Abstract][Full Text] [Related]
43. Neutrophils promote experimental choroidal neovascularization.
Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
[TBL] [Abstract][Full Text] [Related]
44. A human neutralizing antibody specific to Ang-2 inhibits ocular angiogenesis.
Rennel ES; Regula JT; Harper SJ; Thomas M; Klein C; Bates DO
Microcirculation; 2011 Oct; 18(7):598-607. PubMed ID: 21851472
[TBL] [Abstract][Full Text] [Related]
45. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
46. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
47. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
[TBL] [Abstract][Full Text] [Related]
48. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
50. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
51. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
52. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
53. Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors.
Juárez CP; Muiño JC; Guglielmone H; Sambuelli R; Echenique JR; Hernández M; Luna JD
Eur J Ophthalmol; 2000; 10(1):51-9. PubMed ID: 10744206
[TBL] [Abstract][Full Text] [Related]
54. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.
Dal Monte M; Martini D; Latina V; Pavan B; Filippi L; Bagnoli P
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2181-92. PubMed ID: 22410551
[TBL] [Abstract][Full Text] [Related]
55. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
[TBL] [Abstract][Full Text] [Related]
56. Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.
Mita AC; Takimoto CH; Mita M; Tolcher A; Sankhala K; Sarantopoulos J; Valdivieso M; Wood L; Rasmussen E; Sun YN; Zhong ZD; Bass MB; Le N; LoRusso P
Clin Cancer Res; 2010 Jun; 16(11):3044-56. PubMed ID: 20501621
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.
Talia DM; Deliyanti D; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1186-96. PubMed ID: 27055905
[TBL] [Abstract][Full Text] [Related]
58. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
Spandau UH; Sauder G; Schubert U; Hammes HP; Jonas JB
Br J Ophthalmol; 2005 Jun; 89(6):745-7. PubMed ID: 15923512
[TBL] [Abstract][Full Text] [Related]
59. Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.
Coxon A; Bready J; Min H; Kaufman S; Leal J; Yu D; Lee TA; Sun JR; Estrada J; Bolon B; McCabe J; Wang L; Rex K; Caenepeel S; Hughes P; Cordover D; Kim H; Han SJ; Michaels ML; Hsu E; Shimamoto G; Cattley R; Hurh E; Nguyen L; Wang SX; Ndifor A; Hayward IJ; Falcón BL; McDonald DM; Li L; Boone T; Kendall R; Radinsky R; Oliner JD
Mol Cancer Ther; 2010 Oct; 9(10):2641-51. PubMed ID: 20937592
[TBL] [Abstract][Full Text] [Related]
60. The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy.
Feng Y; Vom Hagen F; Wang Y; Beck S; Schreiter K; Pfister F; Hoffmann S; Wagner P; Seeliger M; Molema G; Deutsch U; Hammes HP
Thromb Haemost; 2009 Jul; 102(1):120-30. PubMed ID: 19572076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
